NCT06744569View on ClinicalTrials.gov

A Phase I Clinical Trial to Evaluate CU-10101 Unguent

PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

September 12, 2024

Primary Completion Date

September 9, 2025

Study Completion Date

September 9, 2025

Conditions
Atopic Dermatitis
Interventions
DRUG

CU-10101

0.3%CU-10101 ；1%CU-10101 ；2%CU-10101； Placebo

Trial Locations (1)

200433

Shanghai Skin Disease Hospital, Shanghai

Sponsors
All Listed Sponsors
lead

Cutia Therapeutics（Wuxi）Co.,Ltd

INDUSTRY